Key result
The Siemens DCA Vantage System delivers accurate, laboratory-quality point-of-care hemoglobin A1c results that improve clinical decision-making, patient compliance, and outcomes.
The Siemens DCA Vantage System is a point-of-care device described as providing laboratory-quality HbA1c results to improve diabetes management.
May streamline diabetes testing workflows; leaves open confirmation of outcome benefits in rigorous trials.
The Siemens DCA Vantage® System meets laboratory-quality standards, simplifies diabetes testing workflow, and delivers accurate, results shown to improve decision-making, patient compliance, and outcomes.
No takes yet. Share an insight, caveat, or question.
Mardis et al. (2017) studied this question. The Siemens DCA Vantage System delivers accurate, laboratory-quality point-of-care hemoglobin A1c results that improve clinical decision-making, patient compliance, and outcomes.